Related Experiment Video
Updated: Jul 5, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia
Annelies M Zwitserloot1, Adilia Warris, Louis G van't Hek
1Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, The Netherlands.
Abstract:
Disseminated aspergillosis in immunocompromised patients has a mortality rate of almost 100%. Despite the development of new antifungal agents, the outcome of disseminated aspergillosis has only improved slightly, particular in patients with central nervous system (CNS) involvement. The use of combination antifungal therapy might improve the dismal outcome of disseminated aspergillosis. We describe a critically ill adolescent with acute lymphoblastic leukemia who was successfully treated with voriconazole and caspofungin for disseminated aspergillosis with involvement of the lung, brain and thyroid gland.
Insights
Disseminated aspergillosis, a severe fungal infection, has a near 100% mortality rate in immunocompromised patients. Combination antifungal therapy with voriconazole and caspofungin shows promise in treating this aggressive condition, even with central nervous system involvement.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Disseminated aspergillosis carries a high mortality rate, especially in immunocompromised individuals.
- Central nervous system (CNS) involvement significantly worsens the prognosis of disseminated aspergillosis.
- Current antifungal treatments offer limited improvement, necessitating novel therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy of combination antifungal therapy in a critically ill adolescent with disseminated aspergillosis.
- To report a successful treatment outcome in a case of disseminated aspergillosis with multi-organ involvement, including the CNS.
Main Methods:
- Case report of a patient with acute lymphoblastic leukemia and disseminated aspergillosis.
- Treatment administered: combination therapy with voriconazole and caspofungin.
- Involvement of lung, brain, and thyroid gland was documented.
Main Results:
- Successful treatment of disseminated aspergillosis in a critically ill adolescent.
- Positive response to combination therapy with voriconazole and caspofungin.
- Resolution of infection despite CNS and multi-organ involvement.
Conclusions:
- Combination antifungal therapy, specifically voriconazole and caspofungin, can be effective in treating disseminated aspergillosis.
- This therapeutic approach may improve outcomes in immunocompromised patients with severe invasive fungal infections.
- Successful management of disseminated aspergillosis with CNS involvement is achievable.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Leishmaniasis
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...